AstraZeneca reported 10.23B in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 11288M 2467M
Alcon AG ALC:SW 1.94B 24M
Amgen AMGN:US $ 4.42B 680M
Artemis Alpha ATS:LN 872K 40K
Astrazeneca AZN:US 10.23B 280M
AstraZeneca AZN:SS 10.23B 280M
AstraZeneca AZN:LN 10.23B 280M
Bayer BAYN:GR 12.65B 2.22B
Biogen BIIB:US $ 2648.2M 727.1M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Fresenius FRE:GR 9.17B 355M
Fresenius Medical Care FME:GR 4.42B 215.3M
Galapagos GLPG:NA 223.9M 58.73M
Genmab GEN:DC 1.61B 205M
Gilead Sciences GILD:US $ 4231M 2162M
GlaxoSmithKline GSK:LN 5.85B 1.13B
Hikma Pharmaceutical HIK:LN 964M 118M
Lonza Group LONN:SW 2.34B 4M
Merck MRK:GR 4.39B 366M
Merk MRK:US $ 9666M 666M
Novartis NOVN:VX 10.86B 895M
Orion ORNBV:FH 201.7M 2.6M
Pfizer PFE:US $ 15640M 148M
Philips PHIA:NA € 4166M 67M
Recordati REC:IM 373.98M 85.87M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M